After signing up, you'll start to receive regular news updates from us.
ProFACT Proteomics Receives New Jersey Entrepreneurial Partnering Fund Award
Complete the form below to unlock access to ALL audio articles.
ProFACT Proteomics, Inc. has received an Entrepreneurial Partnering Fund award from the New Jersey Commission on Science and Technology on May 19, 2006.
The funds will, in part, support a $516,000 Research and Development program with Principal Investigator Kiran Madura, PhD and his laboratory at the University of Medicine and Dentistry of New Jersey (UMDNJ).
"We are grateful to the Commission for this opportunity to accelerate the development of new molecular profiling methods which, we foresee will enhance the characterization of multiple forms of Cancer," said CEO David Golub.
The project is jointly overseen by Dr. Madura and ProFACT Chief Scientific Officer Swapan Roy, PhD who said, "This program will allow us to demonstrate our unique profiling capabilities for important and challenging cancer proteomic applications."
The project will amplify Dr. Madura’s research involving the Ubiquitin/Proteasome Pathway, which degrades and eliminates unwanted or misformed proteins and is thus essential to cell function.
By incorporating SeraFILE™, ProFACT’s differential subfractionation technology, key elements of this pathway may be revealed.
"Our goal is to generate new cancer profiles, and ultimately, new diagnostics and therapeutics down the road," said Dr. Madura.
